GRACE :: Treatments & Symptom Management
GRACE Video

2015 Immunotherapy Patient Forum Videos

Share
 
The videos below were filmed at the November 2015 Immunotherapy Patient Forum. Please note that the information presented in the videos was accurate in November 2015, but progress in immunotherapy changes rapidly. If you have questions about the information in these videos, please post them in the GRACE forum.
 

IO_2015_Gulley_Immunotherapy_Defined_Action_Mechanisms
What is Immunotherapy & Its Mechanisms of Action?
31:01
 
Dr. James Gulley, National Cancer Institute, gives an overview of the immune system and describes the mechanism of action of immunotherapy agents, as well as results from clinical trials.
 
IO_2015_Atkins_Current_Role_Immunotherapy_Cancer_Patients
The Current Role of Immunotherapy in the Treatment of Patients with Cancer
35:06
 
Dr. Michael Atkins, Georgetown-Lombardi Comprehensive Cancer Center, details the positive trial results for immunotherapy in a wide variety of cancers. He also describes current trials of combination regimens and the future of immunotherapy.
 
IO_2015_Lipson_Managing_Immunotherapy_Side_Effects
Managing Immunotherapy Side Effects
12:39
 
Dr. Evan J. Lipson, Johns Hopkins University, discusses the incidence and treatment of side effects of immunotherapy and compares them to chemotherapy toxicities.
 
IO_2015_Immunotherapy_Patient_Perspective
The Patient Perspective
5:34
 
Terrie Schmith, a stage IV melanoma survivor, describes her battle with the disease and her successful treatment with pebrolizumab.
 
IO_2015_Genitourinary_Prostate_Bladder_Kidney_Cancer_Immunotherapy
Immunotherapy for Genitourinary Cancers
14:45
 
Dr. James Gulley, National Cancer Institute, discusses immunotherapies for genitourinary cancers, including recent trial results. He also addresses early data which may indicate that using immunotherapy sooner may benefit patients.
 
IO_2015_Lung_Cancer_Immunotherapy_NSCLC_SCLC
Immunotherapy for Lung Cancer
42:48
 
Dr. Julie Brahmer, Johns Hopkins University, discusses immunotherapies for NSCLC and SCLC, analyzes the relevant trial data and addresses the unique side effects of these therapies.
 
IO_2015_Melanoma_Defined_Immunotherapy_Treatment
Immunotherapy for Melanoma
40:33
 
Dr. Mario Sznol, Yale School of Medicine, provides an overview of melanoma and its treatment, and discusses current melanoma immunotherapies and other agents under investigation.
 
IO_2015_Brahmer_Biomarkers_Patient_Selection
Immunotherapy Biomarkers and Patient Selection
24:18
 
Dr. Julie Brahmer, Johns Hopkins University, discusses the use of biomarker testing and mutational burden to select patients for specific immunotherapies in lung cancer, renal cell carcinoma and melanoma.
 
IO_2015_Sznol_Novel_Immunotherapies_Combinations
Novel Immunotherapies and Combinations
25:33
 
Dr. Mario Sznol, Yale School of Medicine, provides a detailed description of the mechanism of action of immunotherapy agents and discusses early data on the use of combination therapies.
 
IO_2015_Slingluff_New_Immunotherapy_Approaches
New Approaches to Immunotherapy
17:59

 
Dr. Craig L. Slingluff, University of Virginia, discusses novel approaches to immunotherapy, including adoptive T-cell therapy, personalized cancer vaccines and personalized selection of immune therapies.

Ask Us, Q&A
Cancer Treatments / Symptom Management Expert Content

Archives

Share

GRACE Cancer Video Library - Lung Cancer Videos

 

2015_Immunotherapy_Forum_Videos

 

2015 Acquired Resistance in Lung Cancer Patient Forum Videos

Share

Join the GRACE Faculty

Lung/Thoracic Cancer Blog
Breast Cancer Blog
Pancreatic Cancer Blog
Kidney Cancer Blog
Bladder Cancer Blog
Head/Neck Cancer Blog
Share

Subscribe to the GRACEcast Podcast on iTunes

Share

Email Newsletter icon, E-mail Newsletter icon, Email List icon, E-mail List icon

Subscribe to
GRACE Notes
   (Free Newsletter)

Other Resources

Share

ClinicalTrials.gov


Biomedical Learning Institute

peerview_institute_logo_243